Effect of Cytochrome P450 Polymorphisms on Platelet Reactivity After Treatment With Clopidogrel in Acute Coronary Syndrome
Open Access
- 13 February 2008
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 101 (8) , 1088-1093
- https://doi.org/10.1016/j.amjcard.2007.11.065
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrelJournal of Thrombosis and Haemostasis, 2007
- Impact of Platelet Reactivity After Clopidogrel Administration on Drug-Eluting Stent ThrombosisJournal of the American College of Cardiology, 2007
- Impact of the Degree of Peri-Interventional Platelet Inhibition After Loading With Clopidogrel on Early Clinical Outcome of Elective Coronary Stent PlacementJournal of the American College of Cardiology, 2006
- Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjectsBlood, 2006
- Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantationEuropean Heart Journal, 2006
- Platelet Reactivity in Patients and Recurrent Events Post-StentingJournal of the American College of Cardiology, 2005
- Variability in platelet responsiveness to clopidogrel among 544 individualsJournal of the American College of Cardiology, 2005
- Clopidogrel Resistance Is Associated With Increased Risk of Recurrent Atherothrombotic Events in Patients With Acute Myocardial InfarctionCirculation, 2004
- Contribution of Hepatic Cytochrome P450 3A4 Metabolic Activity to the Phenomenon of Clopidogrel ResistanceCirculation, 2004
- Clopidogrel for Coronary StentingCirculation, 2003